Tianjin CanSinotech Biotechnology's Private Equity Round

Tianjin CanSinotech Biotechnology raised a round of funding on April 18, 2017.

Tianjin CanSino Biotechnology (CanSino) is a biotechnology company dedicated to the R&D, manufacturing and commercialization of vaccine products for human use. The company's goal is to lead and grow C…

Articles about Tianjin CanSinotech Biotechnology's Private Equity Round: